G. Pierantoni

发表

Homeodomain-interacting Protein Kinase-2 Stabilizes p27kip1 by Its Phosphorylation at Serine 10 and Contributes to Cell Motility*

G. Viglietto, A. Fusco, S. Soddu, 2011, The Journal of Biological Chemistry.

Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy.

S. Staibano, A. Fusco, G. Pierantoni, 2004, Journal of molecular endocrinology.

The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues.

A. Ballabio, M. Santoro, A. Fusco, 2002, Biochemical and biophysical research communications.

Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.

M. Santoro, A. Fusco, G. Pierantoni, 2008, Cancer research.

Malignant Phenotype in Thyroid Cancer Gene Expression Correlates with a Highly CBX 7 Loss of the Updated

M. Santoro, A. Fusco, G. Pierantoni, 2008 .

A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas.

G. Viglietto, R. Visone, M. Santoro, 2003, Carcinogenesis.

Thyroid cell transformation requires the expression of the HMGA1 proteins

M. Santoro, A. Fusco, G. Pierantoni, 2002, Oncogene.

Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells

C. Procaccini, G. Matarese, A. Kisslinger, 2013, PloS one.

High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria

G. Chiappetta, A. Fusco, G. Pierantoni, 2012, Cell Death and Disease.

Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

C. Croce, A. Klein-Szanto, R. Visone, 2002, Oncogene.

Retraction: Identification of new high mobility group A1 associated proteins

A. Fusco, G. Pierantoni, F. Esposito, 2007, Proteomics.

High mobility group A1 protein modulates autophagy in cancer cells

M. Renna, A. Fusco, G. Pierantoni, 2017, Cell Death and Differentiation.

Establishment of a non‐tumorigenic papillary thyroid cell line (FB‐2) carrying the RET/PTC1 rearrangement

M. Nikiforova, Y. Nikiforov, M. Santoro, 2002, International journal of cancer.

Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression

L. De Rosa, G. Pierantoni, A. Conti, 2022, Frontiers in Genetics.

HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.

G. Botti, G. Chiappetta, M. Monaco, 2008, European journal of cancer.

Mitochondrial Malfunctioning, Proteasome Arrest and Apoptosis in Cancer Cells by Focused Intracellular Generation of Oxygen Radicals

G. Palumbo, G. Pierantoni, E. Roscetto, 2015, International journal of molecular sciences.

Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations

M. T. Pellecchia, P. Barone, G. De Michele, 2018, Cell Death & Disease.

Phenotypic Effects of Homeodomain-Interacting Protein Kinase 2 Deletion in Mice

G. Pierantoni, O. Paciello, S. Paladino, 2021, International journal of molecular sciences.

High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.

P. Chieffi, A. Fusco, G. Pierantoni, 2010, Cancer research.

Genetic ablation of Hipk 2 induces cardiac dysfunction and , in combination with the loss of Hmga 1 , causes respiratory distress and thyroid dysfunction in mice

G. Pierantoni, Francesca Cammarota, 2018 .

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype

A. Fusco, A. Barbieri, G. Palma, 2014, Biology Open.

Double knock-out of Hmga1 and Hipk2 genes causes perinatal death associated to respiratory distress and thyroid abnormalities in mice

A. Fusco, G. Pierantoni, M. Tornincasa, 2019, Cell Death & Disease.

HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity

A. Fusco, G. Bossi, S. Soddu, 2015, Oncotarget.

Convergent Effects of Resveratrol and PYK2 on Prostate Cells

C. Procaccini, G. Matarese, A. Kisslinger, 2016, International journal of molecular sciences.

The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas.

C. Croce, A. Fusco, G. Pierantoni, 2002, Cancer research.

The High Mobility Group A 2 Gene Is Amplified and Overexpressed in Human Prolactinomas 1

C. Croce, A. Fusco, G. Pierantoni, 2002 .

CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1

A. Scaloni, M. Santoro, A. Fusco, 2010, Oncogene.

Overexpression of Proteins HMGA 1 Induces Cell Cycle Deregulation and Apoptosis in Normal Rat Thyroid Cells 1

G. Viglietto, M. Santoro, A. Fusco, 2001 .

HIPK2 in cancer biology and therapy: Recent findings and future perspectives.

G. Pierantoni, S. Paladino, A. Conte, 2022, Cellular signalling.

PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.

P. Cappabianca, A. Fusco, G. Pierantoni, 2012, Endocrine-related cancer.

High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.

A. Fusco, G. Pierantoni, F. Esposito, 2005, Endocrine-related cancer.

HMGA1 protein is a novel target of the ATM kinase.

C. Croce, P. Chieffi, A. Fusco, 2008, European journal of cancer.

Transforming properties of Felis catus papillomavirus type 2 E6 and E7 putative oncogenes in vitro and their transcriptional activity in feline squamous cell carcinoma in vivo.

L. Pacini, G. Pierantoni, M. Tommasino, 2016, Virology.

Cytokines and VEGF Induction in Orthodontic Movement in Animal Models

L. Perillo, G. Pierantoni, L. Berrino, 2012, Journal of biomedicine & biotechnology.

Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo

G. Viglietto, G. Chiappetta, M. Santoro, 1998, Oncogene.

Photodynamic and Antibiotic Therapy in Combination to Fight Biofilms and Resistant Surface Bacterial Infections

G. Palumbo, G. Pierantoni, E. Roscetto, 2015, International journal of molecular sciences.

High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2.

A. Fusco, S. Soddu, M. Mottolese, 2007, The Journal of clinical investigation.

HMGA1 and HMGA2 protein expression in mouse spermatogenesis

P. Chieffi, A. Fusco, S. D. Agostino, 2002, Oncogene.

Pax8 has a critical role in epithelial cell survival and proliferation

M. Zannini, A. Fusco, S. Soddu, 2013, Cell Death and Disease.

Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma.

R Rullo, G. Pierantoni, R. Rullo, 2011, Anticancer research.

Thymosin beta-10 gene expression as a possible tool in diagnosis of thyroid neoplasias.

G. Chiappetta, M. Monaco, A. Fusco, 2004, Oncology reports.

Hmga2 is necessary for Otx2-dependent exit of embryonic stem cells from the pluripotent ground state

A. Fusco, T. Russo, G. Pierantoni, 2016, BMC Biology.

Hmga1 null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities

A. Fusco, C. Rinaldo, G. Pierantoni, 2016, Cell cycle.

Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes

A. Fusco, E. Medico, C. Rinaldo, 2015, Oncotarget.

HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs

A. Fusco, C. Arra, G. Pierantoni, 2014, Oncotarget.

Deregulation of microRNA expression in thyroid neoplasias

A. Fusco, G. Pierantoni, P. Pallante, 2014, Nature Reviews Endocrinology.

High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ

A. Fusco, G. Pierantoni, M. Fedele, 2012 .

FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders

Liliane A. T. Arnaldi, G. D'aiuto, G. Botti, 2007, BMC Cancer.

High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity

A. Fusco, S. Soddu, M. Mottolese, 2006, Cell Death and Differentiation.

HMGA1 Protein Overexpression in Human Breast Carcinomas

G. D'aiuto, G. Botti, G. Chiappetta, 2004, Clinical Cancer Research.

HMGA 1 Protein Overexpression in Human Breast Carcinomas : Correlation with ErbB 2 Expression

G. D'aiuto, G. Botti, G. Chiappetta, 2004 .

HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia.

N. Zanesi, G. Chiappetta, M. Santoro, 2003, International journal of oncology.

High-mobility group A1 proteins are overexpressed in human leukaemias.

G. Chiappetta, A. Fusco, F. Lo Coco, 2003, The Biochemical journal.

Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

C. Croce, A. Fusco, G. Pierantoni, 2003, Molecular and Cellular Biology.

Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells.

G. Viglietto, M. Santoro, A. Fusco, 2018, Cancer research.

Neoplastic transformation of rat thyroid cells requires the junB and fra‐1 gene induction which is dependent on the HMGI‐C gene product

G. Viglietto, M. Santoro, P. Verde, 1997, The EMBO journal.

Critical Role of the HMGA2 Gene in Pituitary Adenomas

R. Visone, A. Fusco, G. Pierantoni, 2006, Cell cycle.

Hmga2 is necessary for Otx2-dependent exit of embryonic stem cells from the pluripotent ground state

A. Fusco, T. Russo, G. Pierantoni, 2016, BMC Biology.

E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression

R. Visone, A. Fusco, G. Pierantoni, 2006, Cell Division.

Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation

G. Viglietto, C. Croce, G. Condorelli, 2001, Molecular and Cellular Biology.

High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).

C. Croce, R. Visone, A. Fusco, 2005, The Biochemical journal.

High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth

G. Viglietto, M. Santoro, A. Fusco, 2001, Oncogene.

Interaction between HMGA1 and Retinoblastoma Protein Is Required for Adipocyte Differentiation*

P. Chieffi, A. Fusco, S. Scala, 2009, The Journal of Biological Chemistry.

High-mobility-group A 1 ( HMGA 1 ) proteins downregulate the expression of the recombination activating gene 2 ( RAG 2 )

C. Croce, R. Visone, A. Fusco, 2005 .

Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2.

P. D. Dal Cin, G. Viglietto, M. Santoro, 2018, Cancer research.

Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells

M. Santoro, A. Fusco, G. Pierantoni, 2003, Oncogene.

RNF4 is a growth inhibitor expressed in germ cells but not in human testicular tumors.

G. Viglietto, P. Chieffi, M. Santoro, 2001, The American journal of pathology.

2 The Genetics of Pituitary Adenomas

A. Fusco, G. Pierantoni, M. Fedele, 2012 .

PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts

M. T. Pellecchia, M. Renna, P. Barone, 2019, Front. Neurosci..

SOM230, A New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary Adenomas

A. Ciarmiello, R. Visone, A. Fusco, 2007, Clinical Cancer Research.

Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.

A. Fusco, G. Pierantoni, F. Esposito, 2012, The Journal of clinical endocrinology and metabolism.

Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype

A. Fusco, G. Pierantoni, M. Tornincasa, 2015, Cell Death and Disease.

Interplay between steroid receptors and neoplastic progression in sarcoma tumors

A. Fiorelli, M. Santini, G. Pierantoni, 2011, Journal of cellular physiology.

Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs

G. Pierantoni, S. Paladino, R. Faraonio, 2018, Cellular Physiology and Biochemistry.

Effects of Long-Term Citrate Treatment in the PC3 Prostate Cancer Cell Line

G. Pierantoni, S. Paladino, M. Mallardo, 2019, International journal of molecular sciences.

Comprehensive conventional and molecular cytogenetic characterization of B-CPAP, a human papillary thyroid carcinoma-derived cell line.

C. Lee, C. Morton, A. Fusco, 2004, Cancer genetics and cytogenetics.

HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody.

E. Cundari, A. Fusco, S. Soddu, 2012, Molecular cell.

Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders

G. Pierantoni, A. Giovane, R. Gerlini, 2014, BioMed research international.

Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice.

G. Viglietto, G. Chiappetta, M. Santoro, 2009, Endocrine-related cancer.

Impairment of the p 27 kip 1 function enhances thyroid carcinogenesis in TRK-T 1 transgenic mice

G. Viglietto, G. Chiappetta, M. Santoro, 2009 .

thyroid carcinogenesis in TRK-T1 transgenic mice

G. Viglietto, G. Chiappetta, M. Santoro, 2009 .

ANew Somatostatin Analogue , Is Highly Effective in the Therapy of Growth Hormone / Prolactin-Secreting PituitaryAdenomas

A. Ciarmiello, A. Fusco, G. Pierantoni, 2007 .

[Ehlers-Danlos syndrome].

G. Pierantoni, G. Stoppoloni, L. Coscia Porrazzi, 1968, La Pediatria.

PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context

A. Fusco, G. Pierantoni, M. Fedele, 2013, Cell Death and Disease.

Phloroglucinol-Derived Medications are Effective in Reducing Pain and Spasms of Urinary and Biliary Tracts: Results of Phase 3 Multicentre, Open-Label, Randomized, Comparative Studies of Clinical Effectiveness and Safety

G. Pierantoni, E. Magli, A. Corvino, 2022, Advances in Therapy.

Two children with diabetes insipidus and diabetes mellitus.

G. Pierantoni, G. Stoppoloni, V. Pacelli, 1969, The Lancet.

Effects of Resveratrol on p66Shc phosphorylation in cultured prostate cells

C. Procaccini, G. Matarese, A. Kisslinger, 2015, Translational medicine @ UniSa.

HIPK2 in the physiology of nervous system and its implications in neurological disorders

C. Rinaldo, G. Pierantoni, S. Paladino, 2023, Biochimica et biophysica acta. Molecular cell research.

Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations

M. T. Pellecchia, P. Barone, G. De Michele, 2018, Cell Death & Disease.

Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro.

C. Croce, R. Aqeilan, R. Visone, 2009, DNA and cell biology.

Lithium chloride increases sensitivity to photon irradiation treatment in primary mesenchymal colon cancer cells

P. Delrio, G. Pierantoni, P. Muto, 2020, Molecular medicine reports.

Retraction to: High-mobility group A1 protein inhibits p53-mediated intrinsic apoptosis by interacting with Bcl-2 at mitochondria

G. Chiappetta, A. Fusco, G. Pierantoni, 2014, Cell Death and Disease.

Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs.

G. Pierantoni, A. Conte, 2018, MicroRNA.

The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane

M. Barone, M. Santoro, A. Fusco, 2001, Oncogene.

Cell-penetrating peptides: two faces of the same coin.

G. Pierantoni, S. Paladino, 2020, The Biochemical journal.

The Genetics of Pituitary Adenomas

A. Fusco, G. Pierantoni, M. Jaffrain-Rea, 2012 .

Retraction: High-Mobility Group A1 Proteins Regulate p53-Mediated Transcription of Bcl-2 Gene.

P. Chieffi, A. Fusco, G. Pierantoni, 2018, Cancer research.

HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs

A. Fusco, C. Arra, G. Pierantoni, 2014, Oncotarget.

High-mobility group A 1 inhibits p 53 by cytoplasmic relocalization of its proapoptotic activator HIPK 2

A. Fusco, S. Soddu, M. Mottolese, 2018 .